Showing 2341-2350 of 5016 results for "".
Topical Treatments for Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/topical-treatments-for-hidradenitis-suppurativa/56433/Topical therapies can provide benefit by reducing bacterial burden, decreasing inflammation, and providing symptomatic relief from minor localized flares.Musely Aging Repair Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/musely-aging-repair-cream/24033/New in My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-3/23826/Let’s Talk About Truncal Acne
https://practicaldermatology.com/topics/acne-rosacea/lets-talk-about-truncal-acne/23785/A look at the burden of truncal acne and current treatment options.Liquid Nitrogen Cryotherapy Anesthesia for Botulinum Toxin Injections for Hyperhidrosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/liquid-nitrogen-cryotherapy-anesthesia-for-botulinum-toxin-injections-for-hyperhidrosis/23687/An accessible but underutilized technique can increase patient comfort.Jawline Contouring Treatment with Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/jawline-contouring-treatment-with-injectables/23647/Use of injectables can produce jaw-dropping results.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?Establishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million d